Opportunity or a dead stock?
I am considering whether to buy at a price of 50€ in $BAYN (-0.42%) at a price of 50€. For my long-term investments, I am very concerned about the business model and the future security of this.
With $BAYN (-0.42%) I am personally unsure. On the one hand, I am attracted by the opportunity and the pharmaceutical industry, but on the other hand, I am deterred by Bayer's past...
What is your opinion at 50€ buy?
